Complement Activity Assays Have Limited Value for Monitoring Ravulizumab Treatment
A debate over how best to monitor the immune-blocking drug ravulizumab is raising an important warning for clinicians: routine laboratory ...
A debate over how best to monitor the immune-blocking drug ravulizumab is raising an important warning for clinicians: routine laboratory ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine